When will marijuana be rescheduled?
🗂 Part of event: Will marijuana be rescheduled? →💡 What the odds say
The market puts this at about a 22% chance — unlikely.
No money — just record your call and see if you were right. Yes is at 22% right now.
The market strongly doubts a 2026 rescheduling, as top DOJ officials avoid committing and financial commentators predict the bet will 'go very wrong,' but the odds may undercount the momentum from ongoing administrative reviews.
📊 Base rate: Since the Controlled Substances Act was enacted in 1970, only about 20 substances have been rescheduled, and cannabis has never moved from Schedule I despite decades of advocacy, placing a change within a few months at a historically low probability.
What's driving it
- • DOJ Head Sidesteps Questions on Schedule III Order (Cannabis Business Times, Jul 21) — the top law enforcement official's refusal to commit signals low urgency from the administration.
- • Rescheduling Marijuana: The Bet That May Be About To Go Very Wrong (Yahoo Finance, Jul 19) — a major financial outlet warned the rescheduling timeline is unrealistic, likely dampening Yes sentiment.
- • Feds Say No Cannabis for Military Personnel Even if Rescheduled (NORML, Jul 23) — the policy clarification reminds traders that even a rescheduling would carry restrictions, reducing its perceived impact and urgency.
The case for YES
- • The White House still has the HHS recommendation and DEA review in hand, and a final rule could be published at any time before year-end, as the procedural clock is running.
- • The military statement implicitly treats rescheduling as a real possibility (it addresses 'even if rescheduled'), suggesting agencies are planning for the change.
- • A political incentive exists: President Biden's campaign promised rescheduling, and a move before January 2027 would fulfill that pledge without requiring congressional action.
The case for NO
- • With only five months left in 2026, the DOJ head's sidestepping (Jul 21) indicates the administration is not prioritizing a final order, making a year-end deadline unlikely.
- • The Yahoo Finance analysis (Jul 19) specifically argues the administration's internal delays and legal hurdles make a 2026 rescheduling improbable.
- • Rescheduling would face immediate litigation from prohibitionist groups, which could cause the DEA to postpone any action until after the 2027 election cycle.
What to watch
- • If the DEA publishes a proposed rule or final order in the Federal Register by September 2026, Yes odds would spike to above 50% — watch for any official docket activity.
- • A statement from the Attorney General or White House explicitly endorsing or rejecting a 2026 timeline would sharply move odds, respectively up for Yes or up for No.
- • Release of the 2026 midterm Congressional schedule or a floor vote on a related bill could signal whether lawmakers expect the executive branch to act before year-end.
AI-generated · grounded in recent news + odds · informational only, not advice. Verify on the source platform.
Data from Kalshi’s public API, for informational purposes only. PredictPal is not affiliated with any platform and does not facilitate trading.
Discussion
Loading…
How it resolves
Settled by Kalshi, a CFTC-regulated US exchange, against the official source named in each contract (e.g. a government release or election certification), with an Outcome Review Committee as a backstop for disputes.
Resolution criteria
If marijuana is rescheduled from Schedule I to a lower drug schedule under the Controlled Substances Act before January 1, 2027, then the market resolves to Yes.
ⓘ A market settles under its own written rules, which can lag what looks decided in the news — so the price may not move to 100% the moment an outcome seems obvious.
View the official rules on Kalshi ↗